Background Registry data add important information to randomized controlled trials (RCT)
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …

Aims To assess and compare long-term mortality and predictors thereof in de novo cardiac
resynchronization therapy defibrillators (CRT-D) vs. upgrade from an implantable …

Importance Cardiac resynchronization therapy (CRT) reduces the risk for mortality and heart
failure–related events in select patients. Little is known about the use of CRT in combination …

Background—Candidates for cardiac resynchronization therapy (CRT) receive either a
biventricular pacemaker or a biventricular pacemaker with an implantable cardioverter …

Aim Ventricular tachycardia (VT)/ventricular fibrillation (VF) occurrence after cardiac
resynchronization therapy–defibrillator (CRT-D) replacement is unknown; hence, there is no …

Background Large randomized trials demonstrated the beneficial effect of implantable
cardioverter-defibrillator (ICD) and cardiac resynchronization therapy–defibrillator (CRT-D) …

Background: Trials comparing implantable cardioverter-defibrillator (ICD) therapy with
cardiac resynchronization therapy with a defibrillator (CRT-D) are limited to selected patients …

Introduction: The purpose of this study was to determine predictors of appropriate
implantable defibrillator (ICD) therapy among patients with heart failure who are treated with …

Aims Comorbidity, such as myocardial infarction, diabetes, and renal failure, plays a pivotal
role in the prognosis of a patient with arrhythmias. However, data on the prognostic impact of …

Aims Guidelines recommend the use of an implantable cardioverter‐defibrillator (ICD)
and/or cardiac resynchronization therapy (CRT) device based on the results of randomized …